Common Stock, Shares, Outstanding of Aptevo Therapeutics Inc. from 31 Dec 2015 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Aptevo Therapeutics Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2015 to 30 Sep 2025.
  • Aptevo Therapeutics Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 13,808,966, a 19% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Aptevo Therapeutics Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 13,808,966 -3,241,570 -19% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 3,224,156 -856,509 -21% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 1,458,504 +785,074 +117% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 72,922 +60,964 +510% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 17,050,536 +2,584,833 +18% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 4,080,665 -3,462,775 -46% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 673,430 -6,566,041 -91% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 11,958 -6,454,336 -100% 31 Dec 2023 10-K 14 Feb 2025 2024 FY
Q3 2023 14,465,703 +9,375,059 +184% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 7,543,440 +2,453,588 +48% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 7,239,471 +2,232,230 +45% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 6,466,294 +1,568,151 +32% 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 5,090,644 +194,885 +4% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 5,089,852 +205,337 +4.2% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 5,007,241 +557,819 +13% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 4,898,143 +487,234 +11% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 4,895,759 +1,662,948 +51% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 4,884,515 +1,651,704 +51% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 4,449,422 +1,216,611 +38% 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 4,410,909 +1,176,678 +36% 31 Dec 2020 10-K 24 Mar 2022 2021 FY
Q3 2020 3,232,811 -42,046,433 -93% 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 3,232,811 -41,866,012 -93% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 3,232,811 -41,857,408 -93% 31 Mar 2020 10-Q 13 May 2020 2020 Q1
Q4 2019 3,234,231 -19,574,185 -86% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 45,279,244 +22,601,974 +100% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 45,098,823 +22,430,950 +99% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 45,090,219 +22,648,245 +101% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 22,808,416 +1,202,700 +5.6% 31 Dec 2018 10-K 25 Mar 2020 2019 FY
Q3 2018 22,677,270 +1,250,539 +5.8% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 22,667,873 +1,358,129 +6.4% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 22,441,974 +1,222,024 +5.8% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 21,605,716 +1,333,979 +6.6% 31 Dec 2017 10-K 18 Mar 2019 2018 FY
Q3 2017 21,426,731 +1,180,376 +5.8% 30 Sep 2017 10-Q 13 Nov 2017 2017 Q3
Q2 2017 21,309,744 +21,308,744 30 Jun 2017 10-Q 10 Aug 2017 2017 Q2
Q1 2017 21,219,950 31 Mar 2017 10-Q 12 May 2017 2017 Q1
Q4 2016 20,271,737 +20,271,737 31 Dec 2016 10-K 13 Mar 2018 2017 FY
Q3 2016 20,246,355 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 1,000* 30 Jun 2016 10-Q/A 22 Sep 2016 2016 Q2
Q4 2015 0 31 Dec 2015 10-K 31 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.